Sticky patch could replace dreaded sugar drink test for cystic fibrosis patients

NCT ID NCT06560463

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 33 times

Summary

This study tests whether a continuous glucose monitor (CGM) worn on the skin for 10 days can detect diabetes and pre-diabetes in people with cystic fibrosis as accurately as the standard 2-hour oral glucose tolerance test (OGTT). The OGTT is time-consuming and often skipped, so a simpler method could improve screening. The study will enroll 30 adults with cystic fibrosis who have normal or mildly abnormal glucose tolerance.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.